Updates in recurrent/metastatic nasopharyngeal carcinoma: The evolving role of immune checkpoint inhibitors

touchFOCUS for touchONCOLOGY Listen to Prof. Barbara Burtness as she answers a series of questions focused on the evolving role of immune checkpoint inhibitors  in the first- and subsequent-line settings for recurrent/metastatic nasopharyngeal carcinoma.  The expert Prof. Barbara Burtness, Yale School of Medicine, New Haven, CT, USA This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Coherus BioSciences. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchoncologyime.org/touchfocus_evolving-role-of-icis-in-rm-npc/